Trials / Completed
CompletedNCT01618019
N-3 PUFA and Rheumatoid Arthritis in Korea
Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Patients With Rheumatoid Arthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Hanyang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if supplementation of n-3 polyunsaturated fatty acid (PUFA) can be beneficial for the patients with rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 fatty acid | 5 capsules/day of either n-3 PUFA, containing 2.09 g eicosapentaenoic acid and 1.165 g docosahexaenoic acid |
| DIETARY_SUPPLEMENT | Placebo | 5 capsules/day of placebo containing sunflower with oleic acid (DSM Nutritional products, Switzerland) |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2012-06-13
- Last updated
- 2012-10-02
- Results posted
- 2012-10-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01618019. Inclusion in this directory is not an endorsement.